ZFYVE1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.866100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.225800E-01
Normal-vs-Stage2
8.078300E-02
Normal-vs-Stage3
1.801840E-01
Normal-vs-Stage4
2.729600E-01
Stage1-vs-Stage2
9.283600E-01
Stage1-vs-Stage3
5.899400E-01
Stage1-vs-Stage4
8.668000E-01
Stage2-vs-Stage3
4.598200E-01
Stage2-vs-Stage4
7.690600E-01
Stage3-vs-Stage4
5.230600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.801600E-02
Normal-vs-AfricanAmerican
1.858630E-01
Normal-vs-Asian
1.194580E-01
Caucasian-vs-AfricanAmerican
5.733000E-01
Caucasian-vs-Asian
3.541000E-01
AfricanAmerican-vs-Asian
9.267400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.084610E-01
Normal-vs-Female
9.717900E-02
Male-vs-Female
7.934400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.217400E-01
Normal-vs-Age(41-60Yrs)
2.232400E-01
Normal-vs-Age(61-80Yrs)
6.467700E-02
Normal-vs-Age(81-100Yrs)
7.208200E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.128400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.485000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.166600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.603930E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.659500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.348600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.031600E-02
Normal-vs-Daily Drinker
1.476240E-01
Normal-vs-Weekly Drinker
1.468560E-01
Normal-vs-Occasional Drinker
1.493450E-01
Normal-vs-Social Drinker
2.355200E-01
Non Drinker-vs-Daily Drinker
1.805190E-01
Non Drinker-vs-Weekly Drinker
1.883220E-01
Non Drinker-vs-Occasional Drinker
2.932000E-02
Non Drinker-vs-Social Drinker
7.746200E-02
Daily Drinker-vs-Weekly Drinker
9.070000E-01
Daily Drinker-vs-Occasional Drinker
4.234600E-01
Daily Drinker-vs-Social Drinker
5.811600E-01
Weekly Drinker-vs-Occasional Drinker
5.138600E-01
Weekly Drinker-vs-Social Drinker
6.790400E-01
Occasional Drinker-vs-Social Drinker
8.780800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.181400E-01
Normal-vs-Grade 2
7.946600E-01
Normal-vs-Grade 3
7.791200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.337200E-01
Grade 1-vs-Grade 3
5.833800E-01
Grade 1-vs-Grade 4
8.181400E-01
Grade 2-vs-Grade 3
7.003400E-01
Grade 2-vs-Grade 4
7.946600E-01
Grade 3-vs-Grade 4
7.791200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.773600E-02
Normal-vs-NonDiabetic
1.130570E-01
Diabetic-vs-NonDiabetic
3.570200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.410200E-02
Normal-vs-NoPancreatitis
9.279800E-02
Pancreatitis-vs-NoPancreatitis
4.566400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.034610E-01
Normal-vs-N1
9.708200E-02
N0-vs-N1
8.229000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.012400E-01
Normal-vs-TP53-NonMutant
1.972230E-01
TP53-Mutant-vs-TP53-NonMutant
9.561800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
